You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 297 No. 12, March 28, 2007 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Journalology/ Peer Review/ Authorship
 •Cardiovascular Disease/ Myocardial Infarction
 •Genetics, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Polymorphisms in the CRP Gene and Cardiovascular Events

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their study of polymorphisms in the C-reactive protein (CRP) gene, Dr Lange and colleagues1 found that genetic variation in the CRP gene was associated with CRP levels and that genetic variants were differentially associated with cardiovascular disease (CVD) events in white and black participants. The authors base their hypothesis on an analogous earlier study showing that the association of a PSSK9 variant with both low-density lipoprotein cholesterol (LDL-C) and CVD suggested that lifelong reduction in LDL-C would reduce CVD.

The likely effect of treatments targeting modifiable risk factors for CVD depends on robust causal inference of the risk factor–disease relationship, which is aided by mendelian randomization methods. Because these methods involve formally combining the CRP gene and gene-disease associations,2 it is disappointing that Lange et al did not use their results to provide an estimate of the causal effect of CRP on CVD risk for . . . [Full Text of this Article]

Debbie A. Lawlor, PhD
d.a.lawlor@bristol.ac.uk

Nic Timpson, BA; Roger Harbord, MSc
Department of Social Medicine
University of Bristol
Bristol, England

Shah Ebrahim, DM
Department of Epidemiology and Population Health
London School of Hygiene and Tropical Medicine
London, England

George Davey Smith, DSc
Department of Social Medicine
University of Bristol
Bristol, England



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Polymorphisms in the CRP Gene and Cardiovascular Events—Reply
Leslie A. Lange, Ethan M. Lange, Russell P. Tracy, and Alexander P. Reine
JAMA. 2007;297(12):1317-1318.
EXTRACT | FULL TEXT  

RELATED ARTICLE

Association of Polymorphisms in the CRP Gene With Circulating C-Reactive Protein Levels and Cardiovascular Events
Leslie A. Lange, Christopher S. Carlson, Lucia A. Hindorff, Ethan M. Lange, Jeremy Walston, J. Peter Durda, Mary Cushman, Joshua C. Bis, Donglin Zeng, Danyu Lin, Lewis H. Kuller, Deborah A. Nickerson, Bruce M. Psaty, Russell P. Tracy, and Alexander P. Reiner
JAMA. 2006;296(22):2703-2711.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.